These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9549821)

  • 1. Growth curve model analysis for quality of life data.
    Zee BC
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):757-66. PubMed ID: 9549821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working Party.
    Qian W; Parmar MK; Sambrook RJ; Fayers PM; Girling DJ; Stephens RJ
    Stat Med; 2000 Oct; 19(19):2657-74. PubMed ID: 10986540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials.
    Fairclough DL; Peterson HF; Cella D; Bonomi P
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):781-96. PubMed ID: 9549823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why are missing quality of life data a problem in clinical trials of cancer therapy?
    Fairclough DL; Peterson HF; Chang V
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):667-77. PubMed ID: 9549815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis of quality of life with missing data in cancer clinical trials.
    Troxel AB; Fairclough DL; Curran D; Hahn EA
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):653-66. PubMed ID: 9549814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.
    Souhami RL; Spiro SG; Rudd RM; Ruiz de Elvira MC; James LE; Gower NH; Lamont A; Harper PG
    J Natl Cancer Inst; 1997 Apr; 89(8):577-80. PubMed ID: 9106647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the types of missingness in quality of life data from clinical trials.
    Curran D; Bacchi M; Schmitz SF; Molenberghs G; Sylvester RJ
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):739-56. PubMed ID: 9549820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based methodology for analyzing incomplete quality-of-life data and integrating them into the Q-TWiST framework.
    Mounier N; Ferme C; Flechtner H; Henzy-Amar M; Lepage E
    Med Decis Making; 2003; 23(1):54-66. PubMed ID: 12583455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response rates, survival, and chemotherapy trials.
    Pazdur R
    J Natl Cancer Inst; 2000 Oct; 92(19):1552-3. PubMed ID: 11018082
    [No Abstract]   [Full Text] [Related]  

  • 11. Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study.
    Pujol JL; Daurès JP; Rivière A; Quoix E; Westeel V; Quantin X; Breton JL; Lemarié E; Poudenx M; Milleron B; Moro D; Debieuvre D; Le Chevalier T
    J Natl Cancer Inst; 2001 Feb; 93(4):300-8. PubMed ID: 11181777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample sizes for cancer trials where Health Related Quality of Life is the primary outcome.
    Julious SA; Campbell MJ; Walker SJ; George SL; Machin D
    Br J Cancer; 2000 Oct; 83(7):959-63. PubMed ID: 10970702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical approaches to minimize problems with missing quality of life data.
    Simes RJ; Greatorex V; Gebski VJ
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):725-37. PubMed ID: 9549819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal duration of chemotherapy in advanced non-small cell lung cancer.
    Lustberg MB; Edelman MJ
    Curr Treat Options Oncol; 2007 Feb; 8(1):38-46. PubMed ID: 17634834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
    van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
    Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.
    Rowland KM; Loprinzi CL; Shaw EG; Maksymiuk AW; Kuross SA; Jung SH; Kugler JW; Tschetter LK; Ghosh C; Schaefer PL; Owen D; Washburn JH; Webb TA; Mailliard JA; Jett JR
    J Clin Oncol; 1996 Jan; 14(1):135-41. PubMed ID: 8558188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer.
    De Pas T; Raimondi S; Pelosi G; Spaggiari L; De Braud F; Veronesi G; Maisonneuve P
    Acta Oncol; 2010 May; 49(4):480-4. PubMed ID: 20105088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
    Slevin ML; Clark PI; Joel SP; Malik S; Osborne RJ; Gregory WM; Lowe DG; Reznek RH; Wrigley PF
    J Clin Oncol; 1989 Sep; 7(9):1333-40. PubMed ID: 2549204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chance for prolonging life and decreasing the quality of life by intensive chemotherapy].
    Schreml W
    Verh Dtsch Ges Inn Med; 1986; 92():439-46. PubMed ID: 3028005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.